Latest news
Loading news…
Biotheus
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Zhuhai, Guangdong, China Founded 2018 101-250 employees For Profit
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.
Biotheus was acquired by BioNTech in 2024 for $800M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
6
Patents
43
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Patents granted
- 43
- Trademarks
- 0
- Top patent class
- Organic Chemistry
Company Info
- Founded
- 2018
- Employees
- 101-250
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 71
- HQ
- Zhuhai, Guangdong, China
- Region
- Asia-Pacific (APAC)
- Exit date
- Nov 13, 2024
Signals & Scores
- Heat score
- High
- Trend (7d)
- 3.6
- Trend (30d)
- 7.4
- Trend (90d)
- 4.2
Key People at Biotheus
VP of Discovery Biology & Co-Founder
SVP and Co-Founder
CEO & Founder
6
professional contacts at Biotheus
Contact execs at Biotheus →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Biotheus
Loading news…
FAQs about Biotheus
People who checked this page also checked these
Browse the full Acquirezy directory.